Atellica CH Enzymatic Creatinine_3 (ECre3)
Enzymatic Method, Creatinine. 510(k) K212223, from Siemens Healthcare Diagnostics, Inc. (Tarrytown, NY). Product code JFY, class 2.
As of Nov 19, 2026, K212223 is an FDA 510(k) held by Siemens Healthcare Diagnostics, Inc., substantially equivalent on Nov 24, 2021 after 131 days, with no recalls tied to it in FDA's recall database.
- Review time: 131 days
- Recalls: 0
The Atellica® CH Enzymatic Creatinine_3 (ECre3) assay is for in vitro diagnostic use in the quantitative determination of creatinine in human serum, plasma (lithium heparin and dipotassium EDTA), and urine using the Atellica® CH Analyzer. Such measurements are used in the diagnosis and treatment of renal diseases and in monitoring renal dialysis.
- Advia Chemistry Enzymatic Creatinine_2K070727 · Siemens Medical Solutions Diagnostics · Aug 3, 2007
- Qscheck UisacrK252619 · Qstag, Inc. · Feb 20, 2026
- Yumizen C1200 Creatinine PAPK193649 · Horiba Abx SAS · May 10, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 16, 2021
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files